IFNA1 and systemic lupus erythematosus: Although neither of these possibilities are exclusive of each other, the most striking finding is that the protein species containing Ro52Ex4 are both enriched in in vivo IFN-activated neutrophils and are the main target of anti-Ro52 antibodies in SLE.